These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 32754264)
1. HSPA12A unstabilizes CD147 to inhibit lactate export and migration in human renal cell carcinoma. Min X; Zhang X; Li Y; Cao X; Cheng H; Li Y; Li C; Kong Q; Mao Q; Peng P; Ni Y; Li J; Duan Y; Liu L; Ding Z Theranostics; 2020; 10(19):8573-8590. PubMed ID: 32754264 [No Abstract] [Full Text] [Related]
2. Heat shock protein A12A activates migration of hepatocellular carcinoma cells in a monocarboxylate transporter 4-dependent manner. Min X; Cheng H; Cao X; Chen Z; Zhang X; Li Y; Mao Q; Xue B; Fang L; Liu L; Ding Z Cell Stress Chaperones; 2022 Jan; 27(1):83-95. PubMed ID: 35050463 [TBL] [Abstract][Full Text] [Related]
3. Heat-Shock protein A12A is a novel PCNA-binding protein and promotes hepatocellular carcinoma growth. Cheng H; Cao X; Min X; Zhang X; Kong Q; Mao Q; Li R; Xue B; Fang L; Liu L; Ding Z FEBS J; 2020 Dec; 287(24):5464-5477. PubMed ID: 32128976 [TBL] [Abstract][Full Text] [Related]
5. HSPA12A stimulates "Smurf1-Hif1α-aerobic glycolysis" axis to promote proliferation of renal tubular epithelial cells after hypoxia/reoxygenation injury. Min X; Li Y; Zhang X; Liu S; Chen Z; Mao Q; Kong Q; Wang Z; Liu L; Ding Z Cell Stress Chaperones; 2024 Oct; 29(5):681-695. PubMed ID: 39349238 [TBL] [Abstract][Full Text] [Related]
6. Hepatocyte HSPA12A inhibits macrophage chemotaxis and activation to attenuate liver ischemia/reperfusion injury via suppressing glycolysis-mediated HMGB1 lactylation and secretion of hepatocytes. Du S; Zhang X; Jia Y; Peng P; Kong Q; Jiang S; Li Y; Li C; Ding Z; Liu L Theranostics; 2023; 13(11):3856-3871. PubMed ID: 37441587 [No Abstract] [Full Text] [Related]
7. HSPA12A promotes c-Myc lactylation-mediated proliferation of tubular epithelial cells to facilitate renal functional recovery from kidney ischemia/reperfusion injury. Li Y; Min X; Zhang X; Cao X; Kong Q; Mao Q; Cheng H; Gou L; Li Y; Li C; Liu L; Ding Z Cell Mol Life Sci; 2024 Sep; 81(1):404. PubMed ID: 39277835 [TBL] [Abstract][Full Text] [Related]
8. Knockdown of PLOD3 suppresses the malignant progression of renal cell carcinoma via reducing TWIST1 expression. Xie D; Li J; Wei S; Qi P; Ji H; Su J; Du N; Zhang X Mol Cell Probes; 2020 Oct; 53():101608. PubMed ID: 32585183 [TBL] [Abstract][Full Text] [Related]
9. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis. Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087 [TBL] [Abstract][Full Text] [Related]
10. Jam3 promotes migration and suppresses apoptosis of renal carcinoma cell lines. Li X; Yin A; Zhang W; Zhao F; Lv J; Lv J; Sun J Int J Mol Med; 2018 Nov; 42(5):2923-2929. PubMed ID: 30226554 [TBL] [Abstract][Full Text] [Related]
11. Targeting the testis-specific heat-shock protein 70-2 (HSP70-2) reduces cellular growth, migration, and invasion in renal cell carcinoma cells. Singh S; Suri A Tumour Biol; 2014 Dec; 35(12):12695-706. PubMed ID: 25213699 [TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor suppresses proliferation and metastasis in renal cell carcinoma cell lines via regulating the expression of the epithelial Ca2+ channel TRPV5. Chen Y; Liu X; Zhang F; Liao S; He X; Zhuo D; Huang H; Wu Y PLoS One; 2018; 13(4):e0195844. PubMed ID: 29659618 [TBL] [Abstract][Full Text] [Related]
13. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells. Huang J; Wang X; Wen G; Ren Y Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453 [TBL] [Abstract][Full Text] [Related]
15. LncRNA POU3F3 Promotes Cancer Cell Proliferation, Migration, and Invasion in Renal Cell Carcinoma by Downregulating LncRNA GAS5. Zhang L; Wang C; Ma M Kidney Blood Press Res; 2021; 46(5):613-619. PubMed ID: 34352801 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma. Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475 [TBL] [Abstract][Full Text] [Related]
17. HSPA12A acts as a scaffolding protein to inhibit cardiac fibroblast activation and cardiac fibrosis. Mao Q; Zhang X; Yang J; Kong Q; Cheng H; Yu W; Cao X; Li Y; Li C; Liu L; Ding Z J Adv Res; 2025 Jan; 67():217-229. PubMed ID: 38219869 [TBL] [Abstract][Full Text] [Related]
18. Long intergenic non-coding RNA 1939 eliminates proliferation and migration of human renal cell carcinoma (RCC) cells by down-regulation of miR-154. Zhang R; Zhang W; Xu B; Lv C; Hou J; Zhang G Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):695-702. PubMed ID: 32138544 [TBL] [Abstract][Full Text] [Related]
19. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway. Hong X; Yu JJ Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490 [TBL] [Abstract][Full Text] [Related]
20. Acetylation- and ubiquitination-regulated SFMBT2 acts as a tumor suppressor in clear cell renal cell carcinoma. Xie Q; Hu B; Li H Biol Direct; 2024 May; 19(1):37. PubMed ID: 38734627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]